The global Acute Repetitive Seizures Market size is expected to reach USD 3.19 billion by 2025, according to a new report by Grand View Research, Inc. The report also states that the market will expand at a strong CAGR of 47.8% during the forecast period. Rise in the number of initiatives to increase the awareness about epilepsy is the major factor driving the market.
The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with few major companies and high market share.
Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.
There are several routes of drug administration; out of which, nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.
Request a sample Copy of the Global Acute Repetitive Seizures Market Research Report @ https://www.grandviewresearch.com/industry-analysis/acute-repetitive-seizures-market/request/rs1
Further key findings from the study suggest:
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/5498/ibb
Grand View Research has segmented the global acute repetitive seizures market on the basis of product and region:
Acute Repetitive Seizures Product Outlook (Revenue, USD Million, 2013 – 2025)
Acute Repetitive Seizures Regional Outlook (Revenue, USD Million, 2013 – 2025)
Browse Related Category @
Epilepsy Drugs Market – https://www.grandviewresearch.com/industry-analysis/epilepsy-drugs-market
Anxiety Disorders And Depression Treatment Market – https://www.grandviewresearch.com/industry-analysis/anxiety-disorders-and-depression-treatment-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/acute-repetitive-seizures-market